CWSR
ABBV icon

Chessman Wealth Strategies RIA’s AbbVie ABBV Stock Holding History

Chessman Wealth Strategies RIA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed -$19K – 27
2018
Q3 		$19K Buy
+200
New +$19K 0.02% 104

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Chessman Wealth Strategies RIA's ABBV Position: Q4 2018 in Review

Chessman Wealth Strategies RIA sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 200 shares — an estimated $19K sold.

Chessman Wealth Strategies RIA first reported a position in ABBV in Q3 2018 and held it in 1 quarter. The position peaked at $19K in Q3 2018. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Chessman Wealth Strategies RIA reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • Chessman Wealth Strategies RIA sold 200 AbbVie shares in Q4 2018, an estimated $19K.
  • Chessman Wealth Strategies RIA first reported a position in AbbVie in Q3 2018 and held it in 1 quarter.
  • Chessman Wealth Strategies RIA's AbbVie position peaked at $19K in Q3 2018.
  • 2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Chessman Wealth Strategies RIA's 13F filing for Q4 2018, filed 14 Jan 2019.